Prime Minister Rutte visited Lab Ofichem
Monday 6 June 2016
- Life Cooperative
Prime Minister Rutte visited Lab Ofichem last Wednesday. As part of an innovation tour through the North of the Netherlands, mr. Mark Rutte has visited the Ofichem R&D Lab in Groningen. After opening the conference “Building the future of Health” at the University Medical Center Groningen, Mr. Rutte visited the company Innolab Chemie BV.
Innolab Chemie BV is an initiative of the University of Groningen and the company Syncom BV, which provides laboratory and office space to start-ups, as well to bigger regional companies that have physically located their R&D activities there. Laboratorium Ofichem BV moved her R&D department to the Innolab in 2015 and participated right from the start. Dr. Weite Oldenziel, CEO of Laboratorium Ofichem BV, showed the laboratory facilities and gave further information on the activities for the pharmaceutical industry. He stressed the importance of collaboration between the different companies.
Mr. Rutte emphasized that the North of the Netherlands is important when it comes to innovations and entrepreneurship and he says this is also contributed by the strong collaboration between the Business, Government and Educational institutions in Groningen.
Focus areasLife Cooperative
Wednesday 6 February 2019
High presence talent at Meet&Greets 2019
Wednesday 30 January 2019
LIFE Cooperative: ‘An important ecosystem in the field of ..
Tuesday 15 January 2019
InnoCore Pharmaceuticals will develop contraceptive micron..
Tuesday 4 December 2018
Welcome to new start up EV Biotech
Monday 5 November 2018
Worldwide market at LIFE Cooperatives feet
Monday 3 September 2018
Lode Holding: initiator, participant and part of the Campu..
Tuesday 28 August 2018
A goldmine in Groningen: business in biobanking
Thursday 23 August 2018
Lode Holding & MercachemSyncom at the start of Campus ..
Tuesday 7 August 2018
AGILeBiotics further develops novel antibiotics
Monday 30 July 2018
Worldwide cooperation agreement InnoCore Pharmaceuticals a..